Related Experiment Video
Updated: Aug 1, 2026
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Pharmacogenomics: translating functional genomics into rational therapeutics
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. williams.evans@stjude.org
Science (New York, N.Y.)
|October 16, 1999
Summary
Genetic variations influence how individuals respond to medications, affecting both effectiveness and side effects. Pharmacogenomics uses this genetic information to personalize drug therapy for better patient outcomes.
Area of Science:
- Pharmacogenomics
- Genetics
- Drug Metabolism
Background:
- Individual responses to medications vary significantly.
- Genetic factors are known to influence drug efficacy and toxicity.
- Understanding these genetic influences is crucial for effective drug therapy.
Purpose of the Study:
- To highlight the role of genetic polymorphisms in drug response.
- To emphasize the contribution of pharmacogenomic studies to drug discovery.
- To underscore the scientific basis for personalized medicine.
Main Methods:
- Review of pharmacogenomic studies.
- Analysis of genetic polymorphisms in drug-related genes.
- Correlation of genetic variations with drug disposition and effects.
Main Results:
- Genetic polymorphisms in enzymes, transporters, and receptors impact drug efficacy and toxicity.
- Pharmacogenomic research is clarifying the genetic basis of drug response.
- These findings support the optimization of drug therapy based on individual genetics.
Conclusions:
- Pharmacogenomics provides a scientific foundation for tailoring drug treatments.
- Understanding genetic variations enhances drug discovery and development.
- Personalized medicine based on pharmacogenomics improves therapeutic outcomes.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...